您的位置: 首页 > 农业专利 > 详情页

Rheumatoid Arthritis treatment by Human Antibodies that Bind Human TNFa
专利权人:
ABBOTT BIOTECHNOLOGY LTD.
发明人:
SALFELD, JOCHEN G,ALLEN, DEBORAH J,KAYMAKCALAN, ZEHRA,LABKOVSKY, BORIS,MANKOVICH, JOHN A,MCGUINESS, BRIAN T,ROBERTS, ANDREW J,SAKORAFAS, PAUL,HOOGENBOOM, HENDRICUS R J M,SCHOENHAUT, DAVID,VAUGHAN, TRI
申请号:
NZ58767897
公开号:
NZ587678A
申请日:
1997.02.10
申请国别(地区):
NZ
年份:
2012
代理人:
摘要:
Provided is an isolated human antibody, or an antigen-binding portion thereof, that dissociates from human TNFá with a Kd of 1 x 10-8 M or less and a Koff rate constant of 1 x 10-3 s-1 or less, both determined by surface plasmon resonance, and neutralizes human TNFá cytotoxicity in a standard in vitro L929 assay with an IC50 of 1 x 10-7 M or less in combination with a non-steroidal anti-inflammatory drug, which can be used for the treatment of rheumatoid arthritis. Further provided are amino acid sequences of suitable antibodies and their CDRs.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充